|Study Type:||Phase I|
|Stage:||Primary analysis complete|
|Study Start Date:||NA|
|Study Made Public:||NA|
A Phase I safety and immunogenicity trial of a combination vaccine (NefTat and gp120w61d) formulated with AS02A (GlaxoSmithKline Biologicals) given intramuscularly in HIV-1-uninfected adult participants
HVTN 041 is a Phase I clinical trial to evaluate the safety and immunogenicity of NefTat and gp120w61d formulated with AS02A.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.